Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy

Journal of Cellular Biochemistry

Volumn 99, Issue 6, 2006, Pages 1688-1704

  Xian, Cory J ^a   Cool, Johanna C ^b   Pyragius, Tim ^b   Foster, Bruce K ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b NONE

Author keywords

5 FU; Bone growth arrest; Chemotherapy; Growth plate; Osteoporosis; Side effects

Indexed keywords

ANTIMETABOLITE; FLUOROURACIL; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DEFECT; BONE GROWTH; BONE INJURY; BONE STRUCTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARTILAGE CELL; CELL ACTIVITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; FRACTURE HEALING; GENE INDUCTION; GENE OVEREXPRESSION; GROWTH PLATE; HISTOLOGY; LEG LENGTHENING; MALE; METAPHYSIS; MOLECULAR DYNAMICS; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRABECULAR BONE; UPREGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BONE DEVELOPMENT; BROMODEOXYURIDINE; DNA PRIMERS; FLUOROURACIL; GENE EXPRESSION; GROWTH PLATE; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33751556806     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20889     Document Type: Article

References (57)

1. Ahmed SF, Wallace WH, Kelnar CJ. 1997. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res 48:178-183.
2. Ahmed SF, Wallace WH, Crofton PM, Wardhaugh B, Magowan R, Kelnar CJ. 1999. Short-term changes in lower leg length in children treated for acute lymphoblastic leukaemia. J Pediatr Endocrinol Metab 12:75-80.
3. Angel CA, Pratt CB, Rao BN, Schell MJ, Parham DM, Lobe TE, Fleming ID. 1992. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents. Cancer 69:1487-1491.
4. Beresford JN. 1989. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:278-280.
5. Booth D, Potten CS. 2001. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr 29:16-20.
6. Byers S, Moore AJ, Byard RW, Fazzalari NL. 2000. Quantitative histomorphometric analysis of the human growth plate from birth to adolescence. Bone 27:495-501.
7. Caruso-Nicoletti M, Mancuso M, Spadaro G, Dibenedetto SP, DiCataldo A, Schiliro G. 1993. Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia. Eur J Pediatr 152:730-733.
8. Clayton PE, Shalet SM, Morris-Jones PH, Price DA. 1988. Growth in children treated for acute lymphoblastic leukaemia. Lancet 1:460-462.
9. Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS. 2005. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res 15:72-82.
10. Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH. 1998. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 83:3121-3129.
11. Damron TA, Margulies BS, Strauss JA, O'Hara K, Spadaro JA, Farnum CE. 2003. Sequential histomorphometric analysis of the growth plate following irradiation with and without radioprotection. J Bone Joint Surg Am 85-A:1302-1313.
12. Davies JH, Evans BA, Jenney ME, Gregory JW. 2002. In vitro effects of combination chemotherapy on osteoblasts: Implications for osteopenia in childhood malignancy. Bone 31:319-326.
13. Decaudin D, Marzo I, Brenner C, Kroemer G. 1998. Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy (review). Int J Oncol 12:141-152.
14. Fazzalari NL, Moore AJ, Byers S, Byard RW. 1997. Quantitative analysis of trabecular morphogenesis in the human costochondral junction during the postnatal period in normal subjects. Anat Rec 248:1-12.
15. Friedlanender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. 1984. Effects of chemotherapeutic agents on bone: Short-term methotrexate and doxorubicin treatment in a rat model. J Bone Joint Surg 66A:602-607.
16. Friesen C, Fulda S, Debatin KM. 1999. Cytotoxic drugs and the CD95 pathway. Leukemia 13:1854-1858.
17. Glasser DB, Duane K, Lane JM, Heuley JH, Caparros-Sison B. 1991. The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop 262:93-100.
18. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD. 1996. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774-1783.
19. Halton JM, Atkinson SA, Barr RD. 1998. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia. Int J Cancer Suppl 11:81-84.
20. Hopkins HA, Kovacs CJ, Looney WB, Wakefield JA. 1976. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration. Cancer Biochem Biophys 1:303-312.
21. Hoshi K, Amizuka N, Oda K, Ikehara Y, Ozawa H. 1997. Immunolocalization of tissue non-specific alkaline phosphatase in mice. Histochem Cell Biol 107:183-191.
22. Houchen CW, George RJ, Sturmoski MA, Cohn SM. 1999. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276:G249-G258.
23. Ianotti JP. 1990. Growth plate physiology and pathology. Orthop Clin N Am 21:1-17.
24. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. 2003. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006-2012.
25. Kember NF. 1993. Cell kinetics and the control of bone growth. Acta Paediatr Suppl 82(Suppl 391):61-65.
26. Kim TH, McLaren J, Alvarado CS, Wyly JB, Crocker I, Winn K, Singhapakdi S, Ragab A. 1989. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma in childhood. Cancer 63:1922-1926.
27. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS. 1999. Recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051-1058.
28. Liu W, Saint DA. 2002. Validation of a quantitative method for real time PCR kinetics. Biochem Biophys Res Commun 294:347-353.
29. Long MW. 2001. Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis 27:677-690.
30. Longley DB, Harkin DP, Johnston PG. 2003. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 3:330-338.
31. Marks SC, Jr. 1998. Osteoclast biology: Lessons from mammalian mutations. Am J Med Genet 34:43-54.
32. McCarthy TL, Centrella M. 2001. Local IGF-I expression and bone formation. Growth Horm IGF Res 11:213-219.
33. Mushtaq T, Ahmed SF. 2002. The impact of corticosteroids on growth and bone health. Arch Dis Child 87:93-96.
34. Peters GJ, van der Wilt CL, van Moorsel CJA, Kroep JR, Bergman AM, Ackland SP. 2000. Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol Ther 87:227-253.
35. Price JS, Oyajobi BO, Russell RG. 1994. The cell biology of bone growth. Eur J Clin Nutr 48(Suppl 1):S131-S149.
36. Robson H, Anderson E, Eden OB, Isaksson O, Shaler SM. 1998. Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation. J Endocrinol 157:225-235.
37. Rosier RN, O'Keefe RJ, Hicks DG. 1998. The potential role of transforming growth factor beta in fracture healing. Clin Orthop Relat Res 355(Suppl):S294-S300.
38. Saade M, Debahy NE, Houjeily S. 1999. Clinical remission of xeroderma pigmentosum-associated squamous cell carcinoma with isotretinoin and chemotherapy: Case report. J Chemother 11:313-317.
39. Samuelsson BO, Marky I, Rosberg S, Albertsson-Wikland K. 1997. Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma. Med Pediatr Oncol 28:27-34.
40. Sanchez CP, He YZ. 2002. Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. Bone 30:692-698.
41. Sasaki H, Sasano H, Ohi R, Imaizumi M, Shineha R, Nakamura M, Shibuya D, Hayashi Y. 1999. Adenocarcinoma at the esophageal gastric junction arising in an 11-year-old girl. Pathol Int 49:1109-1113.
42. Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ. 1991. Abnormal growth patterns and adult short satture in 115 long-term survivors of childhood leukemia. J Clin Oncol 9:400-405.
43. Siebler T, Shalet SM, Robson H. 2002. Effects of chemotherapy on bone metabolism and skeletal growth. Horm Res 58(Suppl 1):80-85.
44. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Coffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA. 2000. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103.
45. Snir M, Lusky M, Shalev B, Gaton D, Weinberger D. 2000. Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Ophthalmic Surg Lasers 31:31-37.
46. Tillman DM, Petak I, Houghton JA. 1999. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clin Cancer Res 5:425-430.
47. Turner CH, Owan I, Alvey T, Hulman J, Hock JM. 1998. Recruitment and proliferative responses of osteoblasts after mechanical loading in vivo determined using sustained-release bromodeoxyuridine. Bone 22:463-469.
48. van Leeuwen BL, Kamps WA, Hartel RM, Veth RP, Sluiter WJ, Hoekstra HJ. 2000a. Effect of single chemotherapeutic agents on the growth skeleton of the rat. Ann Oncol 11:1121-1126.
49. van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ. 2000b. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363-376.
50. Xian CJ. 2003. Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair. Curr Pharm Biotechnol 4:260-269.
51. Xian CJ, Howarth GS, Mardell CE, Cool JC, Familari M, Read LC, Giraud AS. 1999. Temporal changes in TFF3 expression and jeunal morphology during methotrexate-induced damage and repair. Am J Physiol 277:G785-G795.
52. Xian CJ, Cool JC, Howarth GS, Read LC. 2002. Effects of TGF-alpha gene knockout on epithelial cell kinetics and repair of methotrexate-induced damage in mouse small intestine. J Cell Physiol 191:105-115.
53. Xian CJ, Howarth GS, Cool J, Foster BK. 2004a. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats. Bone 35:739-749.
54. Xian CJ, Zhou FH, McCarty RC, Foster BK. 2004b. Intramembranous ossification mechanism for bone bridge formation at the growth plate cartilage injury site. J Orthop Res 22:417-426.
55. Yakar S, Rosen CJ. 2003. From mouse to man: Redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med (Maywood) 228:245-252.
56. Zhou FH, Foster BK, Sander G, Xian CJ. 2004. Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone 35:1307-1315.
57. Zidan J, Kuten A, Rosenblatt E, Robinson E. 1997. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Oral Oncol 33:129-135.